Skip to main content
Top
Published in: Clinical Rheumatology 9/2012

01-09-2012 | Original Article

Correlations between histopathologic and scintigraphic parameters of salivary glands in patients with Sjögren’s syndrome

Authors: Tamer Aksoy, Pinar Ozgen Kiratli, Belkis Erbas

Published in: Clinical Rheumatology | Issue 9/2012

Login to get access

Abstract

The aim of this study is to evaluate the diagnostic value of quantifying salivary gland scintigraphy in correlation to the labial biopsy findings of Sjögren’s syndrome (SS). Thirty patients suspected of having SS referred to our clinic for salivary gland scintigraphy were included to this study. All patients underwent salivary gland biopsy as well. The severity of histopathologic changes was graded according to the Chisholm and Mason scoring system. Dynamic scintigraphy was performed and region of interests (ROI) were drawn. Time activity curves for salivary glands were generated. Count rates of maximum, minimum activity after lemon juice stimuli, and last minute activities of parotid and submandibular glands were obtained. On the basis of this ROI counts, excretion fraction (EF%) was calculated for all salivary glands. The mean EF% for normal parotid gland and pathologic parotid gland was 54.5 ± 13.9 and 45.8 ± 18.42, respectively, while it was 46.7 ± 11.7 for the normal submandibular gland and 29.3 ± 18.8 for the pathologic submandibular gland. With progression in histopathologic grades from 0 to 4, the EF decreased in all salivary glands. Decreased EF in the salivary glands is correlated with the SS, and salivary gland scintigraphy is a sensitive and valid method for evaluation of the function of the salivary glands.
Literature
1.
go back to reference Manoussakis MN, Moutsopoulos HM (2000) Sjögren’s syndrome: autoimmune epithelitis. Baillière’s Best Practice & Research Clin Rheumatol 14:73–95CrossRef Manoussakis MN, Moutsopoulos HM (2000) Sjögren’s syndrome: autoimmune epithelitis. Baillière’s Best Practice & Research Clin Rheumatol 14:73–95CrossRef
2.
go back to reference Vitali C, Bombardieri S, Moutsopoulos HM (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the Americane European consensus group. Ann Rheum Dis 61:554–558PubMedCrossRef Vitali C, Bombardieri S, Moutsopoulos HM (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the Americane European consensus group. Ann Rheum Dis 61:554–558PubMedCrossRef
3.
go back to reference Umehara I, Yamada I, Murata Y, Takahashi Y, Okada N, Shibuya H (1999) Quantitative evaluation of salivary gland scintigraphy in Sjögren’s syndrome. J Nucl Med 40:64–69PubMed Umehara I, Yamada I, Murata Y, Takahashi Y, Okada N, Shibuya H (1999) Quantitative evaluation of salivary gland scintigraphy in Sjögren’s syndrome. J Nucl Med 40:64–69PubMed
4.
go back to reference Schall GL, Anderson LG, Wolf RO et al (1971) Xerostomia in Sjögren’s syndrome: evaluation by sequential salivary scintigraphy. JAMA 216:2109–2116PubMedCrossRef Schall GL, Anderson LG, Wolf RO et al (1971) Xerostomia in Sjögren’s syndrome: evaluation by sequential salivary scintigraphy. JAMA 216:2109–2116PubMedCrossRef
5.
go back to reference Arrago JP, Rain JD, Brocheriou C, Rocher F (1987) Scintigraphy of the salivary glandsin Sjögren’s syndrome. J Clin Pathol 40:1463–1467PubMedCrossRef Arrago JP, Rain JD, Brocheriou C, Rocher F (1987) Scintigraphy of the salivary glandsin Sjögren’s syndrome. J Clin Pathol 40:1463–1467PubMedCrossRef
6.
go back to reference Daniels TE, Powell MR, Sylvester RA, Talal N (1979) An evaluation of salivaryscintigraphy in Sjögren’s syndrome. Arthritis Rheum 22:809–814PubMedCrossRef Daniels TE, Powell MR, Sylvester RA, Talal N (1979) An evaluation of salivaryscintigraphy in Sjögren’s syndrome. Arthritis Rheum 22:809–814PubMedCrossRef
7.
go back to reference Sugihara T, Yoshimura Y (1988) Scintigraphic evaluation of the salivary glands in patients with Sjögren’s syndrome. Int J Oral Maxillofac Surg 17:71–75PubMedCrossRef Sugihara T, Yoshimura Y (1988) Scintigraphic evaluation of the salivary glands in patients with Sjögren’s syndrome. Int J Oral Maxillofac Surg 17:71–75PubMedCrossRef
8.
go back to reference Bohuslavizki KH, Brenner W, Wolf H et al (1995) Value of quantitative salivary gland scintigraphy in the early stage of Sjögren’s syndrome. Nucl Med Commun 16:917–922PubMedCrossRef Bohuslavizki KH, Brenner W, Wolf H et al (1995) Value of quantitative salivary gland scintigraphy in the early stage of Sjögren’s syndrome. Nucl Med Commun 16:917–922PubMedCrossRef
9.
go back to reference Aung W, Yamada I, Umehara I, Ohbayashi N, Yoshino N, Shibuya H (2000) Sjögren’s syndrome: comparison of assessments with quantitative salivary gland scintigraphy and contrast sialography. J Nucl Med 41:257–262PubMed Aung W, Yamada I, Umehara I, Ohbayashi N, Yoshino N, Shibuya H (2000) Sjögren’s syndrome: comparison of assessments with quantitative salivary gland scintigraphy and contrast sialography. J Nucl Med 41:257–262PubMed
10.
go back to reference Klutmann S, Bohuslavizki KH, Kröger S, Bleckmann C, Brenner W, Mester J et al (1999) Quantitative salivary gland scintigraphy. J Nucl Med Technol 27:20–26PubMed Klutmann S, Bohuslavizki KH, Kröger S, Bleckmann C, Brenner W, Mester J et al (1999) Quantitative salivary gland scintigraphy. J Nucl Med Technol 27:20–26PubMed
11.
go back to reference Kosuda S, Suzuki K, Kawakami R, Akita S, Mezaki T, Inokuma S et al (1993) Reassessment of usefulness of salivary scintigraphy in diagnosis of Sjögren’s syndrome. Kaku Igaku (Jpn J Nucl Med) 30:161–170 Kosuda S, Suzuki K, Kawakami R, Akita S, Mezaki T, Inokuma S et al (1993) Reassessment of usefulness of salivary scintigraphy in diagnosis of Sjögren’s syndrome. Kaku Igaku (Jpn J Nucl Med) 30:161–170
12.
go back to reference Chisholm DM, Mason DK (1968) Labial salivary gland biopsy in Sjögren’s syndrome. J Clin Pathol 21:656–660PubMedCrossRef Chisholm DM, Mason DK (1968) Labial salivary gland biopsy in Sjögren’s syndrome. J Clin Pathol 21:656–660PubMedCrossRef
13.
go back to reference Liem IH, Olmos RA, Balm AJ et al (1996) Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumours. Eur J Nucl Med 23:1485–1490PubMedCrossRef Liem IH, Olmos RA, Balm AJ et al (1996) Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumours. Eur J Nucl Med 23:1485–1490PubMedCrossRef
14.
go back to reference Kohn WG, Ship JA, Atkinson JC, Patton LL, Fox PC (1992) Salivary gland 99mTc-scintigraphy: a grading scale and correlation with major salivary gland flow rates. J Oral Pathol Med 21:70–74PubMedCrossRef Kohn WG, Ship JA, Atkinson JC, Patton LL, Fox PC (1992) Salivary gland 99mTc-scintigraphy: a grading scale and correlation with major salivary gland flow rates. J Oral Pathol Med 21:70–74PubMedCrossRef
15.
go back to reference Vigh L, Carlsen O, Hartling OJ (1997) Uptake index and stimulated salivary gland response in 99Tcm-pertechnetate salivary gland scintigraphy in normal subjects. Nucl Med Commun 18:363–366PubMedCrossRef Vigh L, Carlsen O, Hartling OJ (1997) Uptake index and stimulated salivary gland response in 99Tcm-pertechnetate salivary gland scintigraphy in normal subjects. Nucl Med Commun 18:363–366PubMedCrossRef
16.
go back to reference Demangeat R, Didon-Poncelet A, Cherfan J, Demangeat JL (2000) Stimulated salivary pertechnetate clearance revisited: correlation with dynamic scintigraphic indices in sicca syndrome. Clin Nucl Med 25:888–894PubMedCrossRef Demangeat R, Didon-Poncelet A, Cherfan J, Demangeat JL (2000) Stimulated salivary pertechnetate clearance revisited: correlation with dynamic scintigraphic indices in sicca syndrome. Clin Nucl Med 25:888–894PubMedCrossRef
17.
go back to reference Bohuslavizki KH, Brenner W, Tinnemeyer S et al (1995) Quantitative salivary gland scintigraphy derived from 166 normals. Radiol Oncol 29:297–305 Bohuslavizki KH, Brenner W, Tinnemeyer S et al (1995) Quantitative salivary gland scintigraphy derived from 166 normals. Radiol Oncol 29:297–305
18.
go back to reference Gerli R, Muscat C, Giasanti M et al (1997) Quantitative assessment of salivary gland inflamatory inflamation in primary Sjögren’s syndrome: its relationship to different demographic clinical and serological features of the disorder. Br J Rheumatol 36:969–975PubMedCrossRef Gerli R, Muscat C, Giasanti M et al (1997) Quantitative assessment of salivary gland inflamatory inflamation in primary Sjögren’s syndrome: its relationship to different demographic clinical and serological features of the disorder. Br J Rheumatol 36:969–975PubMedCrossRef
19.
go back to reference Vinagre F, Santos MJ, Prata A, Canas da Silva J, Santos AI (2009) Assessment of salivary gland function in Sjögren’s syndrome: the role of salivary gland scintigraphy. Autoimmun Rev 8:672–676PubMedCrossRef Vinagre F, Santos MJ, Prata A, Canas da Silva J, Santos AI (2009) Assessment of salivary gland function in Sjögren’s syndrome: the role of salivary gland scintigraphy. Autoimmun Rev 8:672–676PubMedCrossRef
20.
go back to reference Konttinen YT, Porola P, Konttinen LLA, Ne M, Poduval P (2006) Immunohistopathology of Sjögren’s syndrome. Autoimmun Rev 6:6–20CrossRef Konttinen YT, Porola P, Konttinen LLA, Ne M, Poduval P (2006) Immunohistopathology of Sjögren’s syndrome. Autoimmun Rev 6:6–20CrossRef
Metadata
Title
Correlations between histopathologic and scintigraphic parameters of salivary glands in patients with Sjögren’s syndrome
Authors
Tamer Aksoy
Pinar Ozgen Kiratli
Belkis Erbas
Publication date
01-09-2012
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 9/2012
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-012-2024-2

Other articles of this Issue 9/2012

Clinical Rheumatology 9/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine